SURVEYING PLASMA LEVELS OF TNF ALPHA AND INTERLEUKIN 6 IN LUPUS NEPHRITIS
Main Article Content
Abstract
Objectives: To investigate plasma levels of TNF-alpha, IL-6, and its correlation between TNF-alpha, IL-6 levels with some characteristics of kidney injury in pediatric lupus nephritis. Patients and Methods: Cross-sectional descriptive study compared with the healthy control group. 117 children (87 patients with lupus nephritis and 30 healthy control children) from 9/2019 to 9/2022 at the National Children's Hospital. Results: Mean age of the patient group was 10.94 ± 2.1; 81.6% were female. The median level of plasma TNF-alpha was 4.73 ng/L. It was higher in the disease group than in the healthy control group (3.54 ng/L), p< 0,001. there was a 47.1% increase in TNF-alpha level in LN compared with the control group. The median level of plasma IL6 was 3.19 ng/L, higher than the control group (1.14 ng/L), p < 0.001. the proportion of children with increased IL-6 levels compared to the control group was 56.3%. Elevated levels of TNF-alpha and IL-6 were associated with disease severity through the SLEDAI score. The group of severe and very severe pediatric patients had higher levels of TNF-alpha, IL-6, and the rate of increase level than the group of patients with mild and moderate disease, p<0.001. Conclusions: Elevated plasma levels of TNF-alpha and IL-6 are relatively common and are associated with the severity of pediatric lupus nephritis.
Article Details
Keywords
lupus nephritis, plasma TNF-alpha và IL-6, SLEDAI SCORE
References
2. Alaa A Sabry, et al (2005): Proinflammatory cytokine (TNF alpha and IL-6) in Egyptian SLE patients with lupus nephritis Is it correlated with disease activity? Eur J Gen Med; 2(4):153-158.
3. Aringer M, Zimmermann C, Graninger WB et al (2002): TNF-α is an essential mediator in lupus nephritis. Arthritis Rheum; 46:3418-9.
4. Ernest H. Choy, et al (2020): Translating IL-6 biology into effective treatments. Rheumatology. Volume 16 | June.
5. Levy DM, Kamphuis S (2012): Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am;59:345-64.
6. Lewandowski LB, Schanberg LE, Thielman N, et al (2017): Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.Lupus; 26(2), 186-194.
7. Yasunori Iwata, et al (2011): The Role of Cytokine in the Lupus Nephritis. BioMed Research International.